Publications

Publications on Coagulopathy

Iba, T, Levy, JH, Levi, M, Thachil, J. Coagulopathy in COVID-19. J Thromb Haemost. 2020; 18: 2103– 2109.

Tang, N, Li D, Wang X, SunZ. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis, 18(4), 844–847.

Thachil, J, Tang N, . (2020). ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. Journal of Thrombosis and Haemostasis, 18(5), 1023–1026.

Wu, C et al. (2020). Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine, 180(7), 934–943.

ATTACC Publications

Houston, B., Lawler, P., Goligher, E., Farkouh, M., Bradbury, C., Carrier, M., Dzavik, V., Fergusson, D.,Fowler, R., Galanaud, J., Gross, P., McDonald, E., Husain, M., Kahn, S., Kumar, A., Marshall, J., Murthy, S.,Slutsky, A., Turgeon, A.,... Zarychanski, R. (2020). Anti-Thrombotic Therapy to Ameliorate Complicationsof COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.Clinical Trials (London, England), p.17407745209438

CMAJ Podcasts: Lucas C. Godoy, Ewan C. Goligher, Patrick R. Lawler, Arthur S. Slutsky and Ryan Zarychanski | CMAJ October 05, 2020 192 (40) E1156-E1161; DOI: https://doi.org/10.1503/cmaj.201240